3939 |
Cerebral Protection During TAVR: Why and How? |
Alan C. Yeung |
Apr. 27. 19 |
3938 |
Optimal Antithrombotics After TAVR: Ongoing Trials |
Duk-Woo Park |
Apr. 27. 19 |
3937 |
Can Angio-FFR Change Our Cath Lab Practice? |
Yoshinobu Onuma |
Apr. 27. 19 |
3936 |
Diffuse Tandem Lesion |
Hitoshi Matsuo |
Apr. 27. 19 |
3935 |
Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes |
Jung-Min Ahn |
Apr. 27. 19 |
3934 |
Hyperemia Free Indexes: Algorithms, Diagnostic and Prognostic Performance |
Hitoshi Matsuo |
Apr. 27. 19 |
3933 |
Why Don\'t We Use Physiology More Often in the Cath Lab? |
Takashi Akasaka |
Apr. 27. 19 |
3932 |
[Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] OCT Is Better! |
Yoshinobu Onuma |
Apr. 27. 19 |
3931 |
Application of Hemodynamic Support in AMI Patients |
Hongbing Yan |
Apr. 27. 19 |
3930 |
[Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better! |
Jung-Min Ahn |
Apr. 27. 19 |